
Apyx Medical Corporation APYX
$ 3.44
0.58%
Quarterly report 2025-Q3
added 11-06-2025
Apyx Medical Corporation Interest Expense 2011-2026 | APYX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Apyx Medical Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 M | 15 K | 10 K | 46 K | 8 K | 104 K | 136 K | 158 K | 1.64 M | -7.44 M | -2.29 M | -212 K | 50 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.48 M | -7.44 M | -407 K |
Quarterly Interest Expense Apyx Medical Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 24 K | -1 K | -21 K | - | -19 K | 543 K | 234 K | - | 1 K | 3 K | 8 K | - | 3 K | 2 K | 4 K | - | 25 K | 8 K | 6 K | - | - | - | - | - | 30 K | 38 K | 34 K | - | -105 K | 2 K | 57 K | - | -720 K | -9 K | 49 K | - | -40 K | -39 K | -40 K | - | -41 K | 1.41 M | -9.63 M | - | -54 K | -23 K | -89 K | - | -58 K | -58 K | -58 K | - | -42 K | -46 K | -52 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.41 M | -9.63 M | -222 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 13.73 | -2.21 % | $ 2.06 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 31.12 | -0.34 % | $ 1.43 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 6.82 | 2.95 % | $ 490 M | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 12.98 | -14.39 % | $ 351 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 270.55 | 0.41 % | $ 7.63 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.83 | -0.15 % | $ 5.94 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 74.69 | 1.66 % | $ 111 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.5 | -1.96 % | $ 168 M | ||
|
Electromed
ELMD
|
78 K | $ 24.17 | 1.05 % | $ 204 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 46.25 | 0.61 % | $ 1.44 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
-30 K | $ 9.28 | -9.16 % | $ 265 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 100.65 | 0.15 % | $ 1.28 B | ||
|
Establishment Labs Holdings
ESTA
|
-15.3 M | $ 75.32 | -3.79 % | $ 2.12 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.54 | -0.22 % | $ 122 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 70.57 | 0.4 % | $ 3.85 B | ||
|
Globus Medical
GMED
|
3.41 M | $ 95.47 | -0.77 % | $ 12.9 B | ||
|
Medtronic PLC
MDT
|
402 M | $ 96.23 | -0.44 % | $ 124 B | ||
|
MiMedx Group
MDXG
|
-558 K | $ 4.89 | -7.48 % | $ 723 M | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 1.56 | -4.6 % | $ 61 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.91 | -12.07 % | $ 1.16 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M |